Skip to content

Vivo Prediabetes Study: Online, Live, and Interactive Strength Training for Older Adults With Prediabetes

Evaluating the Feasibility and Acceptability of Vivo, an Online, Live and Interactive Strength Training Program, in Sedentary Older Adults With Prediabetes.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05497960
Enrollment
28
Registered
2022-08-11
Start date
2022-09-01
Completion date
2023-05-15
Last updated
2025-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Loss, Muscle Weakness, Older Adults, PreDiabetes

Keywords

older adults, pre diabetes, strength training, muscle weakness, resistance training, virtual, intervention

Brief summary

This research trial studies the effect of an online, live and interactive strength training program on physical function and strength in older adults with prediabetes.

Detailed description

It is well established that in-person resistance training is an effective form of exercise to increase physical function and quality of life amongst adults. However, older adults report not participating in resistance training due to lack of age appropriate programs, fear of a gym setting, poor access to a gym, joint and other kinds of pain, and lack of social support. These barriers have been compounded as a result of COVID-19 pandemic, wherein older adults are encouraged to socially isolate, leading to even less physical activity. Vivo is a virtual small group exercise program designed for adults 55 and addresses these major barriers to strength training by coaching through an interactive online training session incorporating social support and social engagement. The investigators plan is to test a highly attractive technology platform specifically designed to meet the needs of older adults to demonstrate that resistance training exercise can be scaled and effective with diverse older adults and remove the barrier of having to go to a gym setting to see benefits. The investigators will test feasibility in a real world sample of adults ≥60 with prediabetes, a very prevalent, serious and often silent health condition that affects 1 in 3 adults in the US and is associated with high rates of sarcopenia, or loss of muscle mass. In the next study, Phase II NCT06458530, investigators will examine the effects of Vivo on physical function and glycemic level in sedentary older with prediabetes

Interventions

BEHAVIORALVivo workout

2 days a week for 12 weeks of a live, interactive virtual strength training program. Each class is 45 minutes long and lead by a certified trainer.

Sponsors

Duke University
CollaboratorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
Eric Levian
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 60 years; * Diagnosis of Pre-diabetes within prior 12 months: fasting glucose between 100 to 126 OR HbA1c between 5.7 and 6.4% * Ambulatory and community-dwelling * Sedentary: less than 150 minutes of moderate physical activity OR less than 75 minutes of vigorous physical activity per week * Have not engaged in resistance training for at least 6 months prior to enrollment * Low functioning (defined as able to do at least 1 chair stand without using hand in 30 second but unable to meet the moderate function criteria for age and gender) * Access to WiFi (or internet connection) in defined exercise space * Willing to maintain weight and current diet throughout the study

Exclusion criteria

* Inability to complete physical function assessment or inability to do a chair stand without using hands. * Use of antidiabetic medications * Use of testosterone supplement or replacement * Clinical disorder precluding/interfering with participation or assessments * Unstable angina, arrhythmia, uncontrolled hypertension * End Stage Renal Disease on Hemodialysis * Lower extremity amputation or paralysis * Neurological conditions causing functional or pronounced cognitive impairments * Active malignancy except for non-melanomatous skin cancers * Unable to provide consent * Weight instability

Design outcomes

Primary

MeasureTime frameDescription
Leg Strength Assessed Through a 30 Second Chair Rise Testat 3 months (endpoint)Participants completed as many chair stands as they could in 30 seconds
Workout Attendanceafter each workout session for up to 3 months (endpoint)Attendance to each workout session was tallied. A possible 24 workout sessions were offered for the intervention (12 weeks of 2 days a week for workouts). The number of participants includes everyone who completed intervention, excluding those who stopped intervention at some point. The data reported represents the overall percent attendance of the participants that completed the intervention (N=22 participants). Attendance was calculated by averaging the number of sessions attended divided by the total number of exercise sessions attended (24 sessions).
Intervention Engagement Assessed by Self- Reported Ease of Useat 3 months (endpoint)Participants completed a questionnaire (Likert Scale) on their experience using Vivo. 1= Strong Disagree to 5= Strongly Agree
Program Satisfactionat the 3 month (endpoint)Participants completed the question on a questionnaire to answer What was your overall satisfaction with Vivo? Responses are percentage of participant who reported being satisfied or very satisfied with the Vivo intervention. A higher number indicates higher satisfaction.
Exercise Intervention Trainer Fidelity Checklistover the course of the 12 week interventionThe exercise intervention fidelity as assessed at 4 time points over the course of the 12-week exercise program using a 9-item checklist to ensure unbiased assessment. The purpose was to observe the exercise session to see if the main areas of the intervention were being delivered; workout intensity, safety, and participation and engagement. The results below indicate the percentage of exercise workouts that met the 9-item checklist. A higher score indicates higher fidelity.

Other

MeasureTime frameDescription
Health-related Quality of Life Measured Via the Short Form (SF)-36baseline and at 3 months (endpoint)Change from baseline to 3 months will be assessed (scores range from 0-100 with higher scores indicating better health-related quality of life)
Satisfaction With Life Measured by the 5 Item SWL Questionnaire3 monthsChanges from baseline to 3 months (SWL scores range from 5-35 with higher score indicating greater SWL)
Profile of Mood Survey (POMS)baseline and at 3 months (endpoint)Changes from baseline to 3 months will assess participant's changes in mood.
Perceived Stress Scale Center for Epidemiologic Studies Depression Scale (CES-D)baseline and at 3 months (endpoint)Changes from baseline to 3 months will assess participant's changes in perceived stress. likert scale from 0-4, higher scores indicate higher stress
Exercise Efficacybaseline and at 3 months (endpoint)Changes from baseline to 3 months will be assessed using a questionnaire measuring the participant's confidence in completing exercise related behaviors
Sleep Measured Via the Pittsburgh Sleep Quality Index (PSQI)baseline and at 3 months (endpoint)Change from baseline to 3 months (PSQI scores range from 0-21 with higher scores indicating worse sleep quality)

Countries

United States

Participant flow

Recruitment details

Participants were recruited from electronic medical records in Duke Maestro Care as described in the Clinical Trials Information. All participants who enrolled and were eligible for the trial participated in the feasibility study.

Participants by arm

ArmCount
Vivo Strength Training
Vivo workout: 2 days a week for 12 weeks of a live, interactive virtual strength training program. Each class is 45 minutes long and lead by a certified trainer.
22
Total22

Baseline characteristics

CharacteristicVivo Strength Training
Age, Continuous68.9 years
STANDARD_DEVIATION 6.4
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
22 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Leg strength assessed through a 30 second chair rise test12.1 chair stands
STANDARD_DEVIATION 2.6
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
5 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
16 Participants
Sex: Female, Male
Female
13 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 22
other
Total, other adverse events
3 / 22
serious
Total, serious adverse events
0 / 22

Outcome results

Primary

Exercise Intervention Trainer Fidelity Checklist

The exercise intervention fidelity as assessed at 4 time points over the course of the 12-week exercise program using a 9-item checklist to ensure unbiased assessment. The purpose was to observe the exercise session to see if the main areas of the intervention were being delivered; workout intensity, safety, and participation and engagement. The results below indicate the percentage of exercise workouts that met the 9-item checklist. A higher score indicates higher fidelity.

Time frame: over the course of the 12 week intervention

Population: There were 4 exercise cohorts in this feasibility study, taught by different trainers. To ensure exercise fidelity across the cohorts, 4 exercise sessions from each cohort were observed for a total of 16 observed exercise sessions. A 9-item checklist was used to ensure components of the sessions were being met. The 16 sessions met 96% of the checklist components.

ArmMeasureValue (NUMBER)
Vivo Strength TrainingExercise Intervention Trainer Fidelity Checklist96 percentage of workouts meeting checklist
Primary

Intervention Engagement Assessed by Self- Reported Ease of Use

Participants completed a questionnaire (Likert Scale) on their experience using Vivo. 1= Strong Disagree to 5= Strongly Agree

Time frame: at 3 months (endpoint)

ArmMeasureGroupValue (NUMBER)
Vivo Strength TrainingIntervention Engagement Assessed by Self- Reported Ease of UseEasy to follow workout instructions during class86 percent of participants
Vivo Strength TrainingIntervention Engagement Assessed by Self- Reported Ease of UseLevel system made it easy to tailor intensity and exercises to my abilities95 percent of participants
Vivo Strength TrainingIntervention Engagement Assessed by Self- Reported Ease of UseEasy to sign into class82 percent of participants
Primary

Leg Strength Assessed Through a 30 Second Chair Rise Test

Participants completed as many chair stands as they could in 30 seconds

Time frame: at 3 months (endpoint)

ArmMeasureValue (MEAN)Dispersion
Vivo Strength TrainingLeg Strength Assessed Through a 30 Second Chair Rise Test14.2 number of chair standsStandard Deviation 2.9
Primary

Program Satisfaction

Participants completed the question on a questionnaire to answer What was your overall satisfaction with Vivo? Responses are percentage of participant who reported being satisfied or very satisfied with the Vivo intervention. A higher number indicates higher satisfaction.

Time frame: at the 3 month (endpoint)

ArmMeasureValue (NUMBER)
Vivo Strength TrainingProgram Satisfaction95 percent of participants
Primary

Workout Attendance

Attendance to each workout session was tallied. A possible 24 workout sessions were offered for the intervention (12 weeks of 2 days a week for workouts). The number of participants includes everyone who completed intervention, excluding those who stopped intervention at some point. The data reported represents the overall percent attendance of the participants that completed the intervention (N=22 participants). Attendance was calculated by averaging the number of sessions attended divided by the total number of exercise sessions attended (24 sessions).

Time frame: after each workout session for up to 3 months (endpoint)

Population: 22 participants completed the intervention. Each participant had the opportunity to attend 24 exercise sessions. The attendance rate was calculated based on the number of sessions the participant attended divided by the total possible sessions (24 sessions). The attendance rate was then averaged across the participants who completed the intervention.

ArmMeasureValue (MEAN)
Vivo Strength TrainingWorkout Attendance85 percent of attendance
Other Pre-specified

Exercise Efficacy

Changes from baseline to 3 months will be assessed using a questionnaire measuring the participant's confidence in completing exercise related behaviors

Time frame: baseline and at 3 months (endpoint)

Other Pre-specified

Health-related Quality of Life Measured Via the Short Form (SF)-36

Change from baseline to 3 months will be assessed (scores range from 0-100 with higher scores indicating better health-related quality of life)

Time frame: baseline and at 3 months (endpoint)

Other Pre-specified

Perceived Stress Scale Center for Epidemiologic Studies Depression Scale (CES-D)

Changes from baseline to 3 months will assess participant's changes in perceived stress. likert scale from 0-4, higher scores indicate higher stress

Time frame: baseline and at 3 months (endpoint)

Other Pre-specified

Profile of Mood Survey (POMS)

Changes from baseline to 3 months will assess participant's changes in mood.

Time frame: baseline and at 3 months (endpoint)

Other Pre-specified

Satisfaction With Life Measured by the 5 Item SWL Questionnaire

Changes from baseline to 3 months (SWL scores range from 5-35 with higher score indicating greater SWL)

Time frame: 3 months

Other Pre-specified

Sleep Measured Via the Pittsburgh Sleep Quality Index (PSQI)

Change from baseline to 3 months (PSQI scores range from 0-21 with higher scores indicating worse sleep quality)

Time frame: baseline and at 3 months (endpoint)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026